PERSPECTIVE OF INNOVATION DRUG FORMULATION WITH DARUNAVIR ETHANOLAT

by S. A. Zolotov, N. B. Diomina, G. F. Vasilenko, M. S. Demin
Published 2019-01-01

Determination of the activity of drug-metabolizing enzymes - the prospects for their use in clinical practice

by V. V. Smirnov, E. A. Egorenkov, L. M. Krasnykh, G. F. Vasilenko, G. V. Ramenskaya
Published 2018-02-01

Assessing the impact of the automation on the variability of the «Dissolution» test results as exemplified by «Betahistine hydrochloride tablets 16 mg»

by G. F. Vasilenko, N. S. Dubovik, I. E. Shohin, G. N. Gildeeva, G. V. Ramenskaya, L. A. Pavlova
Published 2018-02-01

Comparative study of perindopril and perindopril metabolite pharmacokinetics using the HPLC/MS method

by L. M. Krasnykh, V. V. Smirnov, E. A. Egorenkov, G. F. Vasilenko, S. P. Dementyev, G. V. Ramenskaya
Published 2018-02-01

Approaches to Pharmaceutical Analysis of Modern Peptide and Oligonucleotide Products as Illustrated by a Small Interfering RNA-Based Novel Therapeutic for the Treatment of Bronchia...

by L. M. Krasnykh, V. V. Smirnov, G. V. Ramenskaya, G. F. Vasilenko, I. P. Shilovsky, M. R. Haitov
Published 2018-09-01

Differences in the pharmacokinetics of ibuprofen in monoand multi-component drugs

by L. M. Krasnykh, V. V. Smirnov, G. F. Vasilenko, O. A. Goroshko, E. A. Egorenkov, V. I. Zozina
Published 2018-02-01